Cell-derived microparticles: new targets in the therapeutic management of disease.
暂无分享,去创建一个
[1] I. Vorobjev,et al. Circulating microparticles: square the circle , 2013, BMC Cell Biology.
[2] Penelope V Dalla,et al. Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells , 2013, PloS one.
[3] U. Wewer,et al. Regulation of ROCK Activity in Cancer , 2013, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[4] F. Sánchez‐Madrid,et al. Transfer of extracellular vesicles during immune cell‐cell interactions , 2013, Immunological reviews.
[5] S. Chakraborti,et al. Implications of calpains in health and diseases. , 2012, Indian journal of biochemistry & biophysics.
[6] R. Cerione,et al. R(h)oads to microvesicles , 2012, Small GTPases.
[7] M. Simionescu,et al. Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? , 2012, Journal of cellular and molecular medicine.
[8] Frederick Luk,et al. Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits , 2012, Molecular Cancer.
[9] A. Guha,et al. Extracellular vesicles – vehicles that spread cancer genes , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[10] A. Goette,et al. Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation. , 2012, Cardiovascular therapeutics.
[11] M. Bebawy,et al. Microparticles and their emerging role in cancer multidrug resistance. , 2012, Cancer treatment reviews.
[12] I. Fleming,et al. All cut up! The consequences of calpain activation on platelet function. , 2012, Vascular pharmacology.
[13] B. Cookson,et al. Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial Life , 2012, Infection and Immunity.
[14] J. Inal,et al. Microvesicles in Health and Disease , 2012, Archivum Immunologiae et Therapiae Experimentalis.
[15] G. Webb,et al. Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-cell P-glycoprotein Transfers in MCF-7 Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.
[16] M. Bebawy,et al. Microparticle‐associated nucleic acids mediate trait dominance in cancer , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] G. Lip,et al. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity , 2011, Basic Research in Cardiology.
[18] G. Grau,et al. Platelets and microparticles in cerebral malaria: the unusual suspects , 2011 .
[19] György Nagy,et al. Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles , 2022 .
[20] Neil O. Carragher,et al. The calpain system and cancer , 2011, Nature Reviews Cancer.
[21] I. Donkor. Calpain inhibitors: a survey of compounds reported in the patent and scientific literature , 2011, Expert opinion on therapeutic patents.
[22] D. Stirling,et al. Microparticles, malignancy and thrombosis , 2011, British journal of haematology.
[23] Jared L. Johnson,et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells , 2011, Proceedings of the National Academy of Sciences.
[24] Françoise Dignat-George,et al. The Many Faces of Endothelial Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[25] J. Freyssinet,et al. Cellular Mechanisms Underlying the Formation of Circulating Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[26] G. Grau,et al. Elevated Cell-Specific Microparticles Are a Biological Marker for Cerebral Dysfunctions in Human Severe Malaria , 2010, PloS one.
[27] P. Brunet,et al. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis , 2010, Thrombosis and Haemostasis.
[28] G. Grau,et al. Microvesiculation and cell interactions at the brain–endothelial interface in cerebral malaria pathogenesis , 2010, Progress in Neurobiology.
[29] J. Freyssinet,et al. Formation of procoagulant microparticles and properties. , 2010, Thrombosis research.
[30] Richard W. Farndale,et al. Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.
[31] G. Grau,et al. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells , 2009, Leukemia.
[32] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[33] H R Büller,et al. Cell-derived microvesicles and cancer. , 2009, The Netherlands journal of medicine.
[34] Loïc Doeuvre,et al. Cell‐derived microparticles: a new challenge in neuroscience , 2009, Journal of neurochemistry.
[35] J. Rak,et al. Microvesicles: Messengers and mediators of tumor progression , 2009, Cell cycle.
[36] P. Fontana,et al. Cell-derived microparticles in haemostasis and vascular medicine , 2009, Thrombosis and Haemostasis.
[37] R. Campbell,et al. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin , 2008, Nature.
[38] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[39] B. Furie,et al. Mechanisms of thrombus formation. , 2008, The New England journal of medicine.
[40] C. Théry,et al. Exosomes from Bronchoalveolar Fluid of Tolerized Mice Prevent Allergic Reaction1 , 2008, The Journal of Immunology.
[41] H. Lage. An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.
[42] A. Tedgui,et al. Role of microparticles in atherothrombosis , 2008, Journal of internal medicine.
[43] Marie-France Penet,et al. Protection against cerebral malaria by the low-molecular-weight thiol pantethine , 2008, Proceedings of the National Academy of Sciences.
[44] J. Freyssinet,et al. Platelet microparticles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses , 2008, Platelets.
[45] E. Angles-cano,et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. , 2007, Blood.
[46] Riitta Lahesmaa,et al. Exosomes with Immune Modulatory Features Are Present in Human Breast Milk1 , 2007, The Journal of Immunology.
[47] J. Liao,et al. Rho Kinase (ROCK) Inhibitors , 2007, Journal of cardiovascular pharmacology.
[48] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[49] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[50] A. Piccin,et al. Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.
[51] H. Schultheiss,et al. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. , 2007, Cardiovascular research.
[52] J. Auger,et al. Thiosulfinates modulate platelet activation by reaction with surface free sulfhydryls and internal thiol-containing proteins , 2007, Platelets.
[53] J. Nolan,et al. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. , 2006, Trends in parasitology.
[54] B. Loriod,et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. , 2006, Blood.
[55] G. Grau,et al. Cell vesiculation and immunopathology: implications in cerebral malaria. , 2006, Microbes and infection.
[56] Masayuki Nakamura,et al. Exploration of orally available calpain inhibitors 2: peptidyl hemiacetal derivatives. , 2006, Journal of medicinal chemistry.
[57] N. Carragher. Calpain inhibition: a therapeutic strategy targeting multiple disease states. , 2006, Current pharmaceutical design.
[58] D. Pisetsky,et al. Microparticles as mediators of cellular cross-talk in inflammatory disease , 2006, Autoimmunity.
[59] B. Furie,et al. Thrombus formation in vivo. , 2005, The Journal of clinical investigation.
[60] Z. Fishelson,et al. Emission of membrane vesicles: roles in complement resistance, immunity and cancer , 2005, Springer Seminars in Immunopathology.
[61] L. Schofield,et al. Immunological processes in malaria pathogenesis , 2005, Nature Reviews Immunology.
[62] T. Iwasaka,et al. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus , 2005, Journal of Human Hypertension.
[63] Graça Raposo,et al. Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.
[64] P. Comfurius,et al. Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.
[65] K. Fukudome,et al. Activated protein C induces the release of microparticle-associated endothelial protein C receptor. , 2005, Blood.
[66] Andre Levchenko,et al. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[67] J. Freyssinet,et al. Membrane microparticles: two sides of the coin. , 2005, Physiology.
[68] M. Hristov,et al. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. , 2004, Blood.
[69] D. Fishman,et al. Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles , 2004, Cancer Research.
[70] Rong-Fong Shen,et al. Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] N. Takahashi,et al. Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. , 2004, Atherosclerosis.
[72] J. Freyssinet,et al. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors , 2004, Current opinion in hematology.
[73] T. Iwasaka,et al. Effect of Ticlopidine on Monocyte-derived Microparticles and Activated Platelet Markers in Diabetes Mellitus , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[74] Hans-Hermann Gerdes,et al. Nanotubular Highways for Intercellular Organelle Transport , 2004, Science.
[75] A. Hafezi-Moghadam,et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A , 2003, Nature Medicine.
[76] R. Nieuwland,et al. Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.
[77] D. E. Goll,et al. The calpain system. , 2003, Physiological reviews.
[78] J. Freyssinet. Cellular microparticles: what are they bad or good for? , 2003, Journal of thrombosis and haemostasis : JTH.
[79] G. Lin,et al. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor. , 2003, Journal of molecular biology.
[80] K. Preissner,et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[81] L. Horstman,et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.
[82] P. Yuen,et al. Structure-activity relationship study and drug profile of N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal (SJA6017) as a potent calpain inhibitor. , 2003, Journal of medicinal chemistry.
[83] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[84] L. Zitvogel,et al. Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.
[85] N. Mohandas,et al. Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[86] L. Qin,et al. Comparison of Pgp- and MRP-Mediated Multidrug Resistance in Leukemia Cell Lines , 2002, International journal of hematology.
[87] J. Auger,et al. Thiosulfinates Inhibit Platelet Aggregation and Microparticle Shedding at a Calpain-dependent Step , 2001, Thrombosis and Haemostasis.
[88] V. Fadok,et al. Apoptotic cell removal , 2001, Current Biology.
[89] Lars Holmgren,et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[90] E. Sahai,et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.
[91] I. Donkor. A survey of calpain inhibitors. , 2000, Current medicinal chemistry.
[92] H. Brühl,et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.
[93] D. Potter,et al. Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading* , 1999, The Journal of Biological Chemistry.
[94] J. Sixma,et al. Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .
[95] D. Dekkers,et al. Lipid translocation across the plasma membrane of mammalian cells. , 1999, Biochimica et biophysica acta.
[96] G. Grau,et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.
[97] L. Holmgren,et al. Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies , 1999, Vox sanguinis.
[98] K. Suzuki,et al. Structure and physiological function of calpains. , 1997, The Biochemical journal.
[99] J. Freyssinet,et al. The significance of human monocyte thrombomodulin during membrane vesiculation and after stimulation by lipopolysaccharide , 1997, British journal of haematology.
[100] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[101] I. Pastan,et al. P-glycoprotein and multidrug resistance. , 1996, Current opinion in genetics & development.
[102] J. Powers,et al. Novel Peptidyl α-Keto Amide Inhibitors of Calpains and Other Cysteine Proteases , 1996 .
[103] E. Lunney,et al. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[104] J. Freyssinet,et al. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. , 1995, Biochemistry.
[105] P. Comfurius,et al. Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. , 1994, Biochimica et biophysica acta.
[106] F. Baas,et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[107] L. Horstman,et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.
[108] P. Sims,et al. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. , 1993, The Journal of biological chemistry.
[109] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[110] M. Dietel,et al. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. , 1992, Biochemical pharmacology.
[111] P. Tracy,et al. Endotoxin enhances the expression of monocyte prothrombinase activity. , 1992, Blood.
[112] C. C. Reynolds,et al. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. , 1991, The Journal of biological chemistry.
[113] C. C. Reynolds,et al. THE ROLE OF CALPAIN IN STIMULUS-RESPONSE COUPLING : EVIDENCE THAT CALPAIN MEDIATES AGONIST-INDUCED EXPRESSION OF PROCOAGULANT ACTIVITY IN PLATELETS , 1990 .
[114] A. Schroit,et al. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. , 1990, Biochimica et biophysica acta.
[115] V. Consalvi,et al. Irreversible inactivation of papain and cathepsin B by epoxidic substrate analogues , 1990 .
[116] J. Philippot,et al. Asymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of guinea pig reticulocytes: Evidence precluding a role for “aminophospholipid translocase” , 1989, Journal of cellular physiology.
[117] B. Kendler. Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. , 1987, Preventive medicine.
[118] Y. Ostchega,et al. Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[119] R. Ganapathi,et al. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells. , 1984, European journal of cancer & clinical oncology.
[120] T. Adachi,et al. Papain inhibitions by optically active E-64 analogs. , 1981, Journal of biochemistry.
[121] T. Tsuruo,et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.
[122] K. Hirschhorn,et al. Observations on cell lines derived from a patient with Hodgkin's disease. , 1978, Cancer research.
[123] P. Wolf. The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.
[124] D. Pisetsky,et al. The role of microparticles in the pathogenesis of rheumatic diseases , 2010, Nature Reviews Rheumatology.
[125] R. Andriantsitohaina,et al. Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. , 2008, Physiological research.
[126] Y. Ikeda,et al. Function and role of microparticles in various clinical settings. , 2008, Thrombosis research.
[127] F. Sharom. ABC multidrug transporters: structure, function and role in chemoresistance. , 2008, Pharmacogenomics.
[128] Link,et al. UvA-DARE ( Digital Academic Repository ) Endothelial cell-derived microparticles , 2007 .
[129] T. Iwasaka,et al. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus , 2007, Journal of Human Hypertension.
[130] E. Bouhassira,et al. Congenital Factor V Deficiency Low Plasma Levels of Tissue Factor Pathway Inhibitor in Patients With , 2006 .
[131] G. Grau,et al. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. , 2005, The American journal of pathology.
[132] K. Nooter,et al. Effects of verapamil on the pharmacokinetics of daunomycin in the rat , 2004, Cancer Chemotherapy and Pharmacology.
[133] H. K. Kim,et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.
[134] M. Gottesman. Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.
[135] G. Ossenkoppele,et al. Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia , 1997 .
[136] K. Imahori,et al. Inhibition of epoxide derivatives on chicken calcium-activated neutral protease (CANP) in vitro and in vivo. , 1980, Journal of biochemistry.